{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:43:47Z","timestamp":1794851027929,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.remnie.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T13:04:22Z","timestamp":1683723862000},"page":"353-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The contribution of PET\/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Adnan","family":"Budak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Yanarate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Budak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2023.05.001_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.remnie.2023.05.001_bib0010","unstructured":"Cancer Research UK. Ovarian cancer survival statistics. [Accessed 20 May 2020]. Available from: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/survival#heading-Three."},{"key":"10.1016\/j.remnie.2023.05.001_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ijgc-00009577-200602001-00016","article-title":"Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer","volume":"16","author":"Murakami","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.remnie.2023.05.001_bib0020","series-title":"StatPearls [Internet]","article-title":"Malignant effusion","author":"Lat","year":"2021"},{"key":"10.1016\/j.remnie.2023.05.001_bib0025","doi-asserted-by":"crossref","first-page":"e1010","DOI":"10.1097\/MD.0000000000001010","article-title":"Diagnostic ability of FDG-PET\/CT in the detection of malignant pleural effusion","volume":"94","author":"Nakajima","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.remnie.2023.05.001_bib0030","article-title":"Can PET\/CT be used more effectively in pleural effusion evaluation?","author":"Simsek","year":"2021","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.remnie.2023.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00259-019-04287-7","article-title":"Development and validation of the PET-CT score for diagnosis of malignant pleural effusion","volume":"46","author":"Yang","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.05.001_bib0040","article-title":"Malignant pleural effusion: diagnosis and management","volume":"2020","author":"Ferreiro","year":"2020","journal-title":"Can Respir J"},{"key":"10.1016\/j.remnie.2023.05.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.remnie.2023.05.001_bib0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/0218492320948311","article-title":"Pleural and serum markers for diagnosis of malignant pleural effusion","volume":"28","author":"Allama","year":"2020","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.remnie.2023.05.001_bib0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/resp.12328","article-title":"Interventional therapies for malignant pleural effusions: the present and the future","volume":"19","author":"Thomas","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.remnie.2023.05.001_bib0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/thoraxjnl-2014-206054","article-title":"Role of CT in assessing pleural malignancy prior to thoracoscopy","volume":"70","author":"Hallifax","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.remnie.2023.05.001_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/thx.52.2.187","article-title":"Evaluation of pleural diseases with FDG-PET imaging: preliminary report","volume":"52","author":"Bury","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.remnie.2023.05.001_bib0070","article-title":"The role of 18F-FDG PET\/CT integra tedimaging in distinguishing malignant from benign pleural effusion","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.remnie.2023.05.001_bib0075","doi-asserted-by":"crossref","first-page":"e1010","DOI":"10.1097\/MD.0000000000001010","article-title":"Diagnostic ability of FDG-PET\/CT in the detection of malignant pleural effusion","volume":"94","author":"Nakajima","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.remnie.2023.05.001_bib0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.mnm.0000243366.96012.c0","article-title":"18F-FDG PET imaging in assessing exudative pleural effusions","volume":"27","author":"Duysinx","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remnie.2023.05.001_bib0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11307-009-0212-5","article-title":"Potential of dual time point FDGPET imaging in differentiating malignant from benign pleural disease","volume":"11","author":"Mavi","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.remnie.2023.05.001_bib0090","first-page":"ii32","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease guideline 2010","volume":"65 Suppl 2","author":"Roberts","year":"2010","journal-title":"Thorax"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225380892300040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225380892300040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:45Z","timestamp":1762418745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S225380892300040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S225380892300040X"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2023.05.001","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of PET\/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2023.03.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}